Introduction: This systematic review evaluated the use of buffered versus non-buffered lidocaine to increase the efficacy of inferior alveolar nerve block (IANB). Materials and Methods: Randomized, double-blinded studies from PubMed, Web of Science, Cochrane Library, Embase, and ProQuest were identified. Two of the authors assessed the studies for risk of bias. Outcomes included onset time, injection pain on a visual analog scale (VAS), percentage of painless injections, and anesthetic success rate of IANB. Results: The search strategy yielded 19 references. Eleven could be included in meta-analyses. Risk of bias was unclear in ten and high in one study. Buffered lidocaine showed 48 seconds faster onset time (95% confidence interval [CI], -42.06 to -54.40; P < 0.001) and 5.0 units lower (on a scale 0-100) VAS injection pain (95% CI, -9.13 to -0.77; P=0.02) than non-buffered. No significant difference was found on percentage of people with painless injection (P = 0.059), nor success rate (P = 0.290). Conclusion: Buffered lidocaine significantly decreased onset time and injection pain (VAS) compared with non-buffered lidocaine in IANB. However due to statistical heterogeneity and low sample size, quality of the evidence was low to moderate, additional studies with larger numbers of participants and low risk of bias are needed to confirm these results.
INTRODUCTION
Lidocaine has been a routine local anesthetic in dentistry since its first introduction into the market in 1948. Inferior alveolar nerve block (IANB) is the primary injection technique for achieving local anesthesia for mandibular dental procedures. To evaluate the anesthetic efficacy of lidocaine in IANB, Vreeland et al. [1] tested lidocaine in different volumes and concentrations in humans. Up to 80% failure of profound analgesic effect in the mandibular teeth were reported [1] . Other anesthetic problems, such as discomfort of solution deposition and slow onset, were also noteworthy to clinicians [1] .
The local anesthetics contain spontaneously uncharged molecules (the base) and positive charged molecules (the cation) [2] . The uncharged free base form of the solution is responsible to diffuse through the nerve sheath, revert to the charged form within the axoplasm, and block the sodium channel to induce nondepolarizing nerve block [2] . The relative proportion of the base and the cation varies with the pH of the solution or the targeting tissues [2] . The higher the pH of the solution, the more free base form of the solution exists. The dissociation constant (pKa) also determines the relative proportion of ionic form [2] . When the pH of the solution equals to the pKa of the local anesthetics, there exist equal amounts of base and cation in the solution. Epinephrine is often used as an addition to local anesthetic agents to achieve prolonged anesthetic effects. However, a lower pH is required for local anesthetics to prolong the shelf life of epinephrine.
The pH of local anesthetics without epinephrine is about 5.5 [2] . When epinephrine is added to lidocaine, to maintain a lower pH value, sodium bisulfite or hydrochloric acid are commonly used in the solution. Thus, the mean pH (± standard deviation, SD) of the solution of 1% lidocaine with 1:100,000 epinephrine is 4.24 (± 0.42), and 2% lidocaine with 1:100,000 epinephrine is 3.93 (± 0.43) [3] . The acidity of lidocaine increases the hydrogen ions in the local tissue environment and thus results in injection pain and increases onset time [2, 4, 5] , which causes the discomfort for patients during IANB injection.
The alkalinization of the lidocaine with sodium bicarbonate can increase the pH value of the solution. When it interacts with the hydrochloride acid in local anesthetics, sodium bicarbonate creates water and carbon dioxide (CO 2 ). Catchlove [6] concluded that CO 2 could potentiate the action of local anesthetics by serving as a direct depressant on the axon, concentrating local anesthetics inside the nerve trunk, and converting local anesthetics to active cations through its effect on pH at the site of action inside the nerve. The alkalinization of lidocaine has been widely evaluated in the medical field. In a systematic review, Davies [7] included 22 randomized clinical trials (RCTs) in humans and concluded that buffering local anesthetics with sodium bicarbonate could reduce injection pain while not affecting efficacy. A more rapid onset can be achieved by increasing the number of uncharged base molecules in the solution [2] .
In 1992, Malamed [8] reported an approach of the addition of sodium bicarbonate immediately prior to anesthetic administration to increase the pH value of the solution in dentistry. After that, several RCTs were conducted to evaluate the effect of sodium bicarbonate buffered lidocaine with epinephrine [5, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . However, the effect of alkalinization of lidocaine in mandibular nerve block remains controversial. This systematic review and meta-analysis aimed to focus on these types of studies to determine whether sodium bicarbonate buffered lidocaine is effective in shortening analgesic onset time, increasing success rate, and reducing injection pain in dental patients receiving an IANB.
MATERIALS AND METHODS

Inclusion and exclusion criteria
The search was limited to randomized controlled trials on healthy volunteers, or asymptomatic patients in need of bilateral dental treatment, or symptomatic patients in need of non-surgical endodontic treatment. The intervention under study was 1-2% buffered lidocaine with 8.4% sodium bicarbonate during IANB injection compared with non-buffered lidocaine. Studies of the effect of articaine [19] , hyaluronidase [20] , or using other buffer agents than sodium bicarbonate (i.e. sodium hydroxide) [21] were excluded. Studies using other routes of administration such as mental nerve block [22] or infiltration prior to IANB [23] were also excluded.
Outcomes
Primary outcome measures were the onset of time of anesthesia in seconds, anesthetic success rate of IANB, the percentage of patients with painless IANB injection, and the pain during IANB injection measured via VAS.
Anesthetic success rate of IANB was defined as the tooth without pain or with mild pain during endodontic access [14, 15] . Injection pain evaluated the level of discomfort or pain for patients when depositing lidocaine solution during the injection procedure. Table 1 shows the data extracted from the full-text articles eligible for inclusion by two independent reviewers (J.G., R.E.). Data extraction included the authors and years of recruitment, demographics of participants and sample size, intervention methods for the study and control groups, study design, and the outcome results for each study ( Table 2 ). The two independent reviewers (J.G., R.E.) resolved any disagreements by open discussion of the issue until an agreement was reached.
Search methods for identification of studies
Data extraction and management
Assessment of risk of bias in RCTs
The risk of bias tool described in the Cochrane Handbook for Systematic Reviews of Interventions [24] was used to assess the risk of bias of each eligible study.
Two independent reviewers (J.G., R.E.) assessed the risk of bias for each included study. Disagreements were resolved by discussion. Table 3 and Fig. 1 show the summary of the risk of bias for each study.
Statistical analyses
Studies were pooled into a meta-analysis only when investigators had used similar interventions and measured similar outcomes. For dichotomous outcomes, risk ratio (RR) with 95% CI were used to express treatment effects.
For continuous data, the authors used difference in means Unclear with 95% CIs. Whenever parallel design and split-mouth design crossover studies were included, the authors conducted paired and independent tests with the same results. For the two studies [13, 17] that provided median, 95% CIs and/or interquartile range (IQR), the methods described by Wan et al. [25] were used to estimate mean and SD. For two studies [9, 11] that reported the VAS score using 170mm scale and two studies [13, 17] using 10 units scales, the authors converted the measurements to 100 mm scale VAS for the meta-analysis. Ph value range was either provided in the included studies or was calculated as described by Frank et al. [3] , and reported in Table 2 . The authors used a random-effects model on combined estimates of effect except when only two studies were included in a meta-analysis, and then the fixed-effect model will be used. Statistics reported were the Cochrane Q test [26] and the I 2 statistic [27] .
Asymptomatic patients who did not take any medication and required dental work and healthy volunteers were separated in the analysis from symptomatic patients.
Separate subgroup analyses were conducted for pediatric and adult patients for injection pain (VAS scores).
Comprehensive Meta-Analysis software Version 3 (Biostat Solutions, Inc; USA) was used to conduct statistical analyses.
Levels of evidence and summary of the review findings
The quality of evidence assessment and summary of the review findings were conducted using the software 
RESULTS
Results of the search
The initial search strategy yielded 57 references, which were reduced to 20 references after removing duplicates.
Twenty studies were assessed independently by two review authors (J.G., K.Y.), and based on the abstracts and titles, one reference [28] was excluded because it was a conference abstract.
All of the 19 manuscripts identified were searched for full-text and analyzed for inclusion independently by two review authors (J.G., K.Y.). Eleven manuscripts were relevant for inclusion [5, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Of these 19 manuscripts, eight were identified for exclusion. Three studies [19] [20] [21] were excluded since they used different intervention:
articaine [19] , buffered with hyaluronidase [20] , and buffered with sodium hydroxide [21] . Two studies [22] , [23] were excluded due to different conditions: mental nerve block [22] , and supplemental buccal infiltration [23] . Two were book chapters [29, 30] and one study [31] was a critical review of one RCT. The preferred
Reporting Items for Systematic Reviews and Metaanalysis (PRISMA) flowchart (Fig. 2) shows a summary of the results. Table 1 shows a list of the included studies.
Included studies
Eleven RCTs evaluating the effect of buffered and non-buffered 1%, 2%, or 4% lidocaine with epinephrine on the effectiveness of IANB were included [5, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] .
Eight of the eleven trials used split mouth technique (the patients' contralateral side was used as the control group) [5, [9] [10] [11] 13, [16] [17] [18] , while three of the eleven studies were parallel RCTs [12, 14, 15] . Inclusion criteria varied among the studies. Two parallel RCTs included patients with symptomatic irreversible pulpitis [14, 15] . Four studies had only healthy volunteers participating in their clinical trials [5, 10, 11, 18] . In two pediatric studies [9, 16] , participants who did not receive any analgesic medication before the appointment and could behave during the procedures were included. One parallel RCT [12] and two split-mouth studies [13, 17] included only patients who required bilateral mandibular treatment.
Risk of bias in included studies
One study demonstrated high risk [11] while the remaining studies showed unclear risk of bias (Fig. 2 , Table 3 ).
Effects of interventions
The eleven included studies comparing buffered lidocaine to non-buffered lidocaine were all incorporated in the meta-analyses as the authors had reported similar outcomes of onset time [9, 11, 12] , VAS scores on injection pain [9] [10] [11] 13, [15] [16] [17] , success rate [14, 15] , and the percentages of painless injection [5, 18] .
Onset time. Four studies [9, 11, 12, 18] reported onset time. Two studies [11, 18] used an electric pulp test (EPT), one testing on mandibular canines [11] and one on mandibular incisors, molars and premolars [18] . These two studies were not combined into a meta-analysis with those checking for gingival probing onset time [9, 12] .
Two studies were included in the meta-analysis [9, 12] (48 seconds) using buffered lidocaine compared to non-buffered lidocaine using the random-effects model (95% CI, -42.06 to -54.40; P < 0.001) (Fig. 3a) .
Success rate of IANB. Only symptomatic patients were included in the meta-analysis. Two studies [14, 15] reported the success rate during IANB using buffered and non-buffered lidocaine in patients with symptomatic irreversible pulpitis. The Q-value was 4.171 with 1 degree of freedom and a P-value of 0.041; I 2 was 76% and the (Fig. 3b) .
VAS score injection pain. Among seven studies reporting VAS injection pain, two studies were excluded from the meta-analysis (Fig. 4a) , and analyzed in sensitivity analyses, due to the heterogeneity of the patients or due to high risk of bias and low pH. (Fig. 4a) . 
VAS pain sensitivity analyses:
a) High risk study and low pH: One study by Donaldson et al. 2006 [11] was assessed at high risk of bias and was using low pH solution in the buffered group (6.83). The pH values of the buffered local anesthetics in the five studies [9, 10, 13, 16, 17] reporting VAS pain were within physiological pH value range (Table 2 ).
Sensitivity analysis including six studies [9] [10] [11] 13, 16, 17] , had similar results (Q-value = 11.752; P = 0.038; I 2 = 57.454). Pooled results showed a significant decrease in injection pain with buffered compared to non-buffered lidocaine of -3.6 VAS pain units on a 0-100 scale (random-effects model; 95% CI, -6.582 to -0.623; P = 0.018).
b) Symptomatic patients:
Only one study [15] included patients with symptomatic irreversible pulpitis, compared to pain-free patients in the other six studies [9] [10] [11] 13, 16, 17] . Sensitivity analysis results including seven studies were similar (random-effects model; difference in means = -3.124; 95% CI, -5.908 to -0.341; P = 0.028).
c) Pediatric patients:
There were two studies [9, 13] that had pediatric patients. In order to evaluate whether patients' ages affect the VAS pain score on injection,
another meta-analysis was conducted which grouped the studies by population (results not shown Small number of studies, small sample size. Table 4 . Summary of the evidence and quality of the findings (GRADE). [34] 0.453; P = 0.077), nor pediatric patients (difference in means, -3.861; 95% CI, -10.927 to 3.206; P = 0.284) for injection pain on VAS scales.
Percentage of painless injection. Three studies [5, 12, 18] reported whether patients experienced painless injection during IANB using buffered and non-buffered lidocaine.
The Q-value was 18.429 with 2 degrees of freedom and a P-value < .0001; I 2 was 89.148%. Pooled results showed no significant increase of the percentage of patients with painless injection when applying buffered lidocaine compared to non-buffered lidocaine using the random effect model (RR, 2.903; 95% CI, 0.961 to 8.771; P = 0.059) (Fig. 4b) .
Levels of evidence and summary of the review findings (according to the GRADE recommendation). The level of evidence for injection pain for IANB using VAS scores was moderate owing to risk of bias. The level of evidence for onset time in seconds was low, due to inconsistency (statistically significant heterogeneity and I 2 larger than 50%) and imprecision (small number of studies included and small sample sizes). The level of evidence for the percentage of patients with painless IANB injection was moderate, due to inconsistency. The level of evidence for success rate of IANB was low, due to inconsistency and imprecision, with only two studies included (Table 4) .
DISCUSSION
This systematic review included eleven studies with 508 participants. Of these eleven studies, one study had high risk of bias [11] while the remaining ten studies had unclear risk of bias. Meta-analysis showed faster onset time of 48 seconds in average, and a decrease in injection pain of 5 units (on a scale 0-100) in the buffered group compared to non-buffered lidocaine.
A recent systematic review [32] has been published in 2018, and has a different PICO question compared to the current systematic review. The aim of the previous systematic review was to investigate the efficacy of buffered local anesthetics in reducing infiltration pain and anesthesia onset time in dentistry. Three IANB studies as well as infiltration studies in adult patients were included. No statistically significant differences in VAS pain for the IANB studies (P = 0.21) and the infiltration studies (P = 0.22) were found. In that systematic review, it is unclear how VAS pain data was obtained for two studies [12, 18] and pediatric patients were not included.
The results of our review are applicable to people aged from 6 years to 81 years, of both genders, who received IANB injection with 1-2% lidocaine with epinephrine.
There was significant heterogeneity in all conducted meta-analyses. Dosage varied from 1.7 mL to 4 mL. The percentage of lidocaine varied among 1% [17] , 4% [15] , The populations included varied as well. There were two studies [9, 13] that had pediatric patients, aging from 6-12 years, and subgroup analyses were conducted by age for VAS injection pain. Two parallel RCTs [14, 15] assessed patients with symptomatic irreversible pulpitis.
As this could be a source of bias because the effectiveness of local anesthetic can be affected by local tissue inflammation [2] , the authors conducted a sensitivity 
CONCLUSIONS
There is moderate quality of evidence to support the use of buffered lidocaine in IANB local anesthesia to decrease injection pain by 5 units on a scale of 0-100 and low quality of evidence to support the effectiveness in reducing onset time. Due to the small sample size and the small number of included studies, further studies are needed to confirm these results. Thus, there is inadequate evidence at this point to recommend the buffered lidocaine for IANB local anesthesia in patients in need of dental treatment.
